USP10 Alleviates Palmitic Acid-induced Steatosis through Autophagy in HepG2 Cells
Authors:
Open Access
- 31 March 2022
- journal article
- research article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 000 (000) , 000
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease caused by over-nutrition. Impaired autophagy is closely related to NAFLD progression. Recently, ubiquitin-specific peptidase-10 (USP10) was reported to ameliorate hepatic steatosis, but the underlying mechanism is still unclear. In view of the potential effects of USP10 on autophagy, we investigated whether USP10 alleviated steatosis through autophagy.Keywords
This publication has 44 references indexed in Scilit:
- Autophagy inhibitorsCellular and Molecular Life Sciences, 2015
- Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathwayAutophagy, 2014
- HTLV-1 Tax oncoprotein stimulates ROS production and apoptosis in T cells by interacting with USP10Blood, 2013
- Stress Granules Inhibit Apoptosis by Reducing Reactive Oxygen Species ProductionMolecular and Cellular Biology, 2013
- Differential Roles of Unsaturated and Saturated Fatty Acids on Autophagy and Apoptosis in HepatocytesThe Journal of Pharmacology and Experimental Therapeutics, 2011
- The AMPK signalling pathway coordinates cell growth, autophagy and metabolismNature Cell Biology, 2011
- Beclin1 Controls the Levels of p53 by Regulating the Deubiquitination Activity of USP10 and USP13Cell, 2011
- In search of an “autophagomometer”Autophagy, 2009
- Autophagy regulates lipid metabolismNature, 2009
- A human hepatocellular in vitro model to investigate steatosisChemico-Biological Interactions, 2007